Skip to main content
. 2014 Nov 28;5:417. doi: 10.3389/fgene.2014.00417

Figure 1.

Figure 1

The clinical utility of whole genome prediction. The number of additional T2DM (red) and Adverse Event (AE, blue) cases prevented as a result of implementing the genomic test at a given decision threshold of predicted weight loss in the context of limited resources.